By Dr Alys Havard

Conference Presentations

Zhou J; Varney B; Bharat C; Degenhardt L; Jones N; Havard A; Tran DT, 2024, 'Retention in opioid agonist treatment following childbirth and associated factors', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=vxBO7_cTwPU&t=97s

Tran D; Varney B; Jones N; Bharat C; Brett J; Oei J; Pearson SA; Degenhardt L; Havard A, 2024, 'Trends in the use of opioid agonist treatment for opioid dependence in pregnancy', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=Cph4ZrfKiMw&t=1850s

Varney B; Bharat C; Brett J; Degenhardt L; Jones N; Oei J; Pearson SA; Havard A; Tran DT, 2024, 'Use of opioid agonist therapy in pregnancy: Timing of initiation and treatment retention', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=Cph4ZrfKiMw&t=2664s

Lin J; Pearson S; Greenfield J; Park KH; Havard A; Brieger D; Day R; Falster M; de Oliveira Costa J, 2023, 'Trends in the use of Cardiometabolic Medicines in Australia (2014-2022): Sodium-glucose Co-transporter 2 Inhibitors and Glucagon-like Peptide-1 Analogues', presented at Australian Diabetes Congress 2023

Lin J; Pearson S; Greenfield J; Park KH; Havard A; Brieger D; Day R; Falster M, 2023, 'Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 analogues (GLP-1a) for cardiovascular risk in Australia (2014-2022)', presented at 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management 2023

Conference Abstracts

Brew B; Murphy V; Gong T; Zoega H; Havard A; Robijn A; Smew A; Rejno G; Lundholm C; Chambers G; Almqvist C, 2025, 'THE ROLE OF INHALED CORTICOSTEROID USE AND ASTHMA EXACERBATIONS IN PREGNANCY ON CHILD ASTHMA RISK', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 55, pp. 7 - 7

Haasdyk BB; Murphy V; Gong T; Zoega H; Havard A; Robijn A; Smew A; Rejno G; Lundholm C; Almqvist C, 2024, 'Asthma exacerbations and inhaled corticosteroid use in pregnancy and child asthma', in EUROPEAN RESPIRATORY JOURNAL, EUROPEAN RESPIRATORY SOC JOURNALS LTD, AUSTRIA, Vienna, Vol. 64, presented at European-Respiratory-Society Congress (ERS), AUSTRIA, Vienna, 07 September 2024 - 11 September 2024, http://dx.doi.org/10.1183/13993003.congress-2024.PA4928

Bruno C; Havard A; Gillies M; Coghill D; Brett J; Guastella A; Pearson S-A; Zoega H, 2022, 'Patterns of ADHD medicine use: A population-based study among Australian children and adults (2013-2020)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 71 - 71, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084400136&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Anderson C; Carcel C; Hsu B; Shajahan S; Miller M; Peters S; Randall D; Havard A; Redfern J; Anderson C; Jorm L; Woodward M, 2022, 'Disparities in the prehospital management of stroke between women and men in New South Wales', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, Vol. 17, pp. 18 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000847720500050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

CHAMBERS GM; CHOI SKY; IRVINE K; VENETIS C; HARRIS K; HAVARD A; NORMAN RJ; LUI K; LEDGER W; JORM LR, 2022, 'ANZARD Data Linkage – Agreement Between Births Recorded by Clinics and in NSW Perinatal Data Collection', in Fertility & Reproduction, World Scientific Pub Co Pte Ltd, Vol. 04, pp. 176 - 176, http://dx.doi.org/10.1142/s2661318222740875

Bruno C; Havard A; Hanly M; Falster K; Nassar N; Edwards B; Guastella A; Pearson S-A; Zoega H, 2021, 'Children's relative age and medicine treatment for attention-deficit/hyperactivity disorder (ADHD) across Australian jurisdictions with different school enrolment policies', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 166 - 167, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300335&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Overs B; Toma C; Havard A; Green M; O'Donnell M; Mitchell P; Schofield P; Fullerton J, 2021, 'Medical morbidity and mortality in Australians with bipolar disorder from linked administrative data', in BIPOLAR DISORDERS, WILEY, Vol. 23, pp. 51 - 52, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000663051300119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Camacho X; Havard A; Zoega H; Wilson M; Gomes T; Vigod S; Pearson S; Henry D, 2020, 'Maternal and Neonatal Outcomes Associated with Psychostimulant Use in Pregnancy', in International Journal of Population Data Science, Swansea University, Vol. 5, http://dx.doi.org/10.23889/ijpds.v5i5.1579

Overs B; Toma C; Havard A; Green MJ; Mitchell PB; Schofield PR; Fullerton JM, 2019, 'Identification and characterisation of bipolar disorder in Australia using administrative health data', in BIPOLAR DISORDERS, WILEY, AUSTRALIA, Sydney, Vol. 21, pp. 69 - 70, presented at 21st Annual ISBD Conference on Global Advances in Bipolar Disorder and Depression, AUSTRALIA, Sydney, 20 March 2019 - 23 March 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461513600148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reutfors J; Zoega H; Cesta C; Bateman BT; Cantarutti A; Cohen J; Corrao G; Einarsdottir K; Engeland A; Furu K; Havard A; Hernandez-Diaz S; Huybrechts KF; Karlsson P; Karlstad O; Li J; Schaffer A; Yu Y; Broms G, 2018, 'Antipsychotic drug use in pregnancy: A multinational database study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 27, pp. 235 - 235

Havard A; Shakeshaft A; Conigrave K, 2009, 'MAILED FEEDBACK FOR AT-RISK DRINKERS PRESENTING TO RURAL EMERGENCY DEPARTMENTS', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, Vol. 28, pp. A28 - A28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reports

Tran DT; Raichand S; Havard A; Jorm L, 2017, Rapid environmental scan and literature review on avoidable hospital readmission indicators

Tran DT; gibson A; randall D; havard A; jorm L, 2015, Mapping the outcomes of calls to the healthdirect helpline

Tran D; Gibson AE; Randall D; Havard A; Jorm L, 2015, Mapping the outcome of calls to the healthdirect helpline (Final Report), Centre for Big Data Research in Health, UNSW Australia

Vogl LE; Newton NC; Teesson M; Swift W; Karageorge A; Deans C; McKetin R; Steadman B; Jones J; Dillon P; Havard AE; Andrews G, 2012, Climate Schools: Universal computer-based programs to prevent alcohol and other drug use in adolescence, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, 321, http://ndarc.med.unsw.edu.au/resource/climate-schools-universal-computer-based-programs-prevent-alcohol-and-other-drug-use

Vogl LE; Newton NC; Teesson M; Swift W; Karageorge A; Havard A; Deans C; McKetin R; Steadman B; Dillon P; Andrews G, 2009, Climate Schools: Drug prevention programs, Prepared for Australian Government Department of Health and Ageing, Sydney

Shanahan M; Havard A; Mills K; Williamson A; Ross J; Teesson M; Darke S; Ali R; Ritter A; Cooke R; Lynskey M, 2003, Health services use and treatment costs over 12 months among heroin users: Findings from the Australian Treatment Outcome Study (ATOS), National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/TR.203.pdf

Ross JE; Lynskey M; Teesson M; Darke S; Havard A; Mills K; Williamson A; Hetherington K; Fairbairn S, 2003, Three Month Outcomes for the Treatment of Heroin Dependence Findings from the Australian Treatment Outcome Study (ATOS), New South Wales, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/TR.159.PDF

Ross J; Lynskey M; Teesson M; Darke S; Havard A; Mills K; Williamson A; Hetherington K; Fairbairn S, 2003, Three month outcomes for the treatment of heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS) New South Wales, NDARC UNSW, Sydney, https://ndarc.med.unsw.edu.au/resource/three-month-outcomes-treatment-heroin-dependence-findings-australian-treatment-outcome

Teesson M; Ross JE; Darke S; Lynskey M; Mills K; Williamson A; Hetherington K; Fairbairn S; Havard A; Wilhelm E; Shanahan M, 2003, Twelve month outcomes of the treatment of heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS) New South Wales, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/TR.191.pdf

Preprints

Varney B; Zoega H; Gillies MB; Bruno C; Havard A; Shand AW; Nassar N; Brett J, 2025, Prenatal prescription opioid analgesic exposure and academic performance in third grade children: An Australian population-based cohort study, http://dx.doi.org/10.22541/au.175533129.98373096/v1

Powell M; Pilkington R; Ahmed T; Hanly M; Newton BJ; Lynch J; Dobbins T; Stewart J; Cretikos M; Havard A; Falster K, 2024, Prevalence of maternal substance use during pregnancy and first two years of life: A whole-population cohort of 970,470 Australian children born 2008-2017, http://dx.doi.org/10.1101/2024.12.09.24318518

Zoega H; Falster M; Gillies M; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer A; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic C; Pearson S-A, 2024, The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia, http://dx.doi.org/10.1101/2024.04.29.24306520

Back to profile page